Antimicrobial Peptide LL‑37 Contributes to Thrombotic Complications in Patients With COVID‑19
Researchers sought to determine the role of LL-37 in patients with SARS-CoV-2 infection and whether it contributes to hypercoagulation.
Researchers sought to determine the role of LL-37 in patients with SARS-CoV-2 infection and whether it contributes to hypercoagulation.
The condition alters the Hifα/Pparα/NF-κB signaling axis, affecting lacrimal gland structure and function.
Researchers sought to determine the underlying reasons for thrombosis risk in patients with severe COVID-19.
Researchers associate the condition with corneal, ocular surface, and meibomian gland changes.